Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar study in patients with neurofibromatosis type 2
ChiCTR-ONRC-14004210Phase 4Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of endostar in neurofibromatosis type 2 (NF2), sponsored by Beijing Tiantan Hospital. Primary endpoints: Tumor volume and Hearing ability. Started Jan 2014; status: completed.
02
Drugs
endostar
03
Conditions
neurofibromatosis type 2 (NF2)
Beyond the preview
Go deeper on ChiCTR-ONRC-14004210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-14004210.